The present study demonstrated that GCN5 is up-regulated in the IL-6–treated TSU, PC-3, LNCaP, and DU145 cells, which suggested a potential role of GCN5 in IL-6–treated PCa cell lines. This evidence concerns the gene KAT2A and posterior cortical atrophy.